These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1828773)

  • 1. A case of hepatitis related to etretinate therapy and hepatitis B vaccine.
    Green C; Lakshmipathi T
    Dermatologica; 1991; 182(2):119-20. PubMed ID: 1828773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic active hepatitis associated with etretinate therapy.
    Weiss VC; Layden T; Spinowitz A; Buys CM; Nemchausky BA; West DP; Emmons KM
    Br J Dermatol; 1985 May; 112(5):591-7. PubMed ID: 4005158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful use of isotretinoin in type Zumbusch generalized pustular psoriasis following recovered etretinate-induced hepatitis].
    Marhold I; Duschet P; Schwarz T; Gschnait F
    Hautarzt; 1991 Sep; 42(9):580-3. PubMed ID: 1938411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etretinate (Tigason) hepatitis in 2 patients.
    van Voorst Vader PC; Houthoff HJ; Eggink HF; Gips CH
    Dermatologica; 1984; 168(1):41-6. PubMed ID: 6698264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential hepatotoxicity of two oral retinoids (etretinate and isotretinoin) in a patient with palmoplantar psoriasis.
    Vahlquist A; Lööf L; Nordlinder H; Rollman O; Vahlquist C
    Acta Derm Venereol; 1985; 65(4):359-62. PubMed ID: 2413699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatotoxic reactions in a patient treated with etretinate.
    Weiss VC; West DP; Ackerman R; Robinson LA
    Arch Dermatol; 1984 Jan; 120(1):104-6. PubMed ID: 6691707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatitis due to etretinate: a case report].
    Navascués CA; Suárez A; Riestra S; Rodrigo L
    Med Clin (Barc); 1991 May; 96(17):679. PubMed ID: 2056805
    [No Abstract]   [Full Text] [Related]  

  • 8. Retinoid hepatitis.
    Sanchez MR; Ross B; Rotterdam H; Salik J; Brodie R; Freedberg IM
    J Am Acad Dermatol; 1993 May; 28(5 Pt 2):853-8. PubMed ID: 8491880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate and etretinate as concurrent therapies in the treatment of psoriasis.
    Zachariae H
    Arch Dermatol; 1984 Feb; 120(2):155. PubMed ID: 6696467
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of skeletal radiographic changes during short-term etretinate therapy for psoriasis.
    Gilbert M; Ellis CN; Voorhees JJ
    Dermatologica; 1986; 172(3):160-3. PubMed ID: 3699217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of etretinate on the liver in psoriasis.
    Camuto P; Shupack J; Orbuch P; Tobias H; Sidhu G; Feiner H
    Am J Surg Pathol; 1987 Jan; 11(1):30-7. PubMed ID: 3789256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term etretinate for pustular psoriasis.
    Rubin MG; Hanno R
    J Am Acad Dermatol; 1985 May; 12(5 Pt 1):896-7. PubMed ID: 4008697
    [No Abstract]   [Full Text] [Related]  

  • 13. Toxic hepatitis due to combination therapy with methotrexate and etretinate in psoriasis.
    Beck HI; Foged EK
    Dermatologica; 1983; 167(2):94-6. PubMed ID: 6628806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk: benefit ratio in the treatment of psoriasis with systemic retinoids.
    Halioua B; Saurat JH
    Br J Dermatol; 1990 Jun; 122 Suppl 36():135-50. PubMed ID: 2142437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholestatic hepatitis occurring shortly after etretinate therapy.
    Kano Y; Fukuda M; Shiohara T; Nagashima M
    J Am Acad Dermatol; 1994 Jul; 31(1):133-4. PubMed ID: 8021361
    [No Abstract]   [Full Text] [Related]  

  • 16. A study of potential hepatotoxicity of etretinate used in the treatment of psoriasis.
    Glazer SD; Roenigk HH; Yokoo H; Sparberg M
    J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):683-7. PubMed ID: 7068976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse hepatic reactions associated with etretinate in patients with psoriasis--analysis of 22 cases.
    Thirumoorthy T; Shupack JL
    Ann Acad Med Singap; 1988 Oct; 17(4):477-81. PubMed ID: 3066276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of HLA antigen for methotrexate-induced liver damage in patients with psoriasis.
    Pestana A; Halprin KM; Taylor JR; Schiff ER; Esquenazi V; Comerford M; Gomez C
    J Am Acad Dermatol; 1985 Jan; 12(1 Pt 1):26-9. PubMed ID: 3980800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Etretinate: pro and con. Risk-benefit analysis of systemic retinoid therapy in psoriasis and recent developments: free aromatic acid, arotinoids].
    Gollnick H; Orfanos CE
    Hautarzt; 1985 Jan; 36(1):2-9. PubMed ID: 3156105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dangers of methotrexate/etretinate combination therapy.
    Zachariae H
    Lancet; 1988 Feb; 1(8582):422. PubMed ID: 2893228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.